GnRH antagonist improved blastocyst quality and pregnancy outcome after multiple failures of IVF/ICSI-ET with a GnRH agonist protocol

Journal of Assisted Reproduction and Genetics

Volumn 21, Issue 9, 2004, Pages 317-322

  Takahashi, Katsuhiko ^a   Mukaida, Tetsunori ^a   Tomiyama, Tatsuhiro ^b   Goto, Tetsuya ^c   Oka, Chikahiro ^c  

^a Hiroshima HART Clinic   (Japan)

^b Osaka HART Clinic   (Japan)

^c Tokyo HART Clinic   (Japan)

Author keywords

Blastocyst; GnRH agonist; GnRH antagonist; multiple ET failures

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; GONADORELIN AGONIST; GONADORELIN ANTAGONIST;

ABORTION; ADULT; ARTICLE; BLASTOCYST; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DELIVERY; DRUG EFFECT; FEMALE; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; INFERTILITY; INJECTION; INTERMETHOD COMPARISON; INTRACYTOPLASMIC SPERM INJECTION; LONG TERM CARE; NIDATION; OOCYTE; OVARY FOLLICLE CELL; OVULATION; PATIENT SELECTION; PREGNANCY; PRIORITY JOURNAL; QUALITY OF LIFE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; ZYGOTE;

ADULT; BLASTOCYST; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HORMONE ANTAGONISTS; HUMANS; PREGNANCY; PREGNANCY OUTCOME; QUALITY CONTROL; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 7044264233     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JARG.0000045470.68525.a4     Document Type: Article

References (25)

1. Bongso A, Ng SC, Fong CY, Anandakumar C, Marshall B, Edirisinghe R, Ratnam S: Improved pregnancy rate after transfer of embryos grown in human fallopian tubal cell coculture. Fertil Steril 1992;58:569-574
2. Wiemer KE, Garris J, Steuerwald N, Alikani MA, Reing AM, Ferrara TA, Noyes N, Cohen J: Beneficial aspects of coculture with assisted hatching when applied to multiple failure in-vitro fertilization patients. Hum Reprod 1996;11:2429-2433
3. Gardner DK, Vella P, Lane M, Wagley L, Schlenker T, Schoolcraft WB: Culture and transfer of human blastocysts increases implantation rates and reduces the need for multiple embryo transfer. Fertil Steril 1998;69:84-88
4. Schoolcraft WB, Gardner DK, Lane M, Schlenker T, Hamilton F, Meldrum DR: Blastocyst culture and transfer: Analysis of results and parameters affecting outcome in two in vitro fertilization programs. Fertil Steril 1999;72:604-609
5. Marek D, Langley M, Gardner DK, Confer N, Doody KM, Doody KJ: Introduction of blastocyst culture and transfer for all patients in an in vitro fertilization program. Fertil Steril 1999;72:1035-1040
6. Milki AA, Hinckley MD, Fisch JD, Dasig D, Behr B: Comparison of blastocyst transfer with day 3 embryo transfer in similar patient populations. Fertil Steril 2000;73:126-129
7. Cruz JR, Dubey AK, Patel J, Peak D, Hartog B, Gindoff P R: Is blastocyst transfer useful as an alternative treatment for patients with multiple in vitro fertilization failures? Fertil Steril 1999;72:218-220
8. Racowsky C, Jackson KV, Cekleniak NA, Fox JH, Homstein MD, Ginsburg ES: The number of eight-cell embryos is a key determinant for selecting day 3 or day 5 transfer. Fertil Steril 2000;73:558-564
9. Jones GM, Trouson AO, Lolatgis N, Wood C: Factors affecting the success of human blastocyst development and pregnancy following in vitro fertilization and embryo transfer. Fertil Steril 1998;70:1022-1029
10. Hughes EG, Sagle MA, Fedorkow DM, Van de Koppel P, Daya S, Collins JA: The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: A meta-analysis of randomized controlled trials. Fertil Steril 1992;58:888-896
11. Minaretzis D, Jakubowski M, Mortola JF, Pavlou SN: Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa-lutein cells. J Clin Endocrinol Metab 1995;80:430-434
12. Olivennes F, Belaisch-Allart J, Emperaire JC, Dechaud H, Alvarez S, Moreau L, Nicollet B, Zorn JR, Bouchard P, Frydman R: Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or depot formula of an LH-RH agonist (triptorelin). Fertil Steril 2000;73:314-320
13. Albano C, Felberbaum RE, Smitz J, Riethmuller-Winzen H, Engel J, Devroy P: Ovarian stimulation with HMG: Results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and the LHRH-agonist buserelin. Hum Reprod 2000;15:526-531
14. Garcia-Velasco JA, Isaza V, Vidal C, Landazabal A, Remohi J, Simon C, Pellicer A: Human ovarian steroid secretion in vivo: Effects of GnRH agonist versus antagonist (cetrorelix). Hum Reprod 2001;16:2533-2539
15. Minaretzis D, Alper MM, Oskowitz SP, Lobel SM, Mortola JF, Pavlou SN: Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: Cycle performance and in vitro steroidogenesis of granulose-lutein cells. Am J Obstet Gynecol 1995;172:1518-1525
16. Craft I, Gorgy A, Hill J, Menon D, Podsiadly B: Will GnRH antagonists provide new hope for patients considered "difficult responders" to GnRH agonist protocols? Hum Reprod 1999;14:2959-2962
17. Mukaida T, Wada S, Takahashi K, Pedro PB, An TZ, Kasai M: Vitrification of human embryos based on the assessment of suitable conditions for 8 cell mouse embryos. Hum Reprod 1998;13:2874-2879
18. Mukaida T, Nakamura S, Tomiyama T, Wada S, Kasai M, Takahashi K: Successful birth after transfer of vitrified human blastocysts with use of a cryoloop containerless technique. Fertil Steril 2001;76:618-620
19. Neveu S, Hedon B, Bringer J, Chinchole JM, Arnal F, Humeau C, Cristol P, Viala JL: Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization. Fertil Steril 1987;47:639-643
20. Palermo R, Amodeo G, Navot D, Rosenwaks Z, Cittadini E: Concomitant gonadotropin-releasing hormone agonist and menotropin treatment for the synchronized induction of multiple follicles. Fertil Steril 1988;49:290-295
21. Tur-Kaspa I, Myers SA, Confino E, Friberg J, Dudkiewicz AB, Gleicher N: Ovarian stimulation protocol for in vitro fertilization with gonadotropin-releasing hormone agonist widens the implantation window. Fertil Steril 1990;53:859-864
22. Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB: Blastocyst score affects implantation and pregnancy outcome: Towards a single blastocyst transfer. Fertil Steril 2000;73:1155-1158
23. Hull MGR, Williams JAC, Ray B, McLaughlin EA, Akande VA, Ford WCL: The contribution of subtle oocyte or sperm dysfunction affecting fertilization in endometriosis-associated or unexplained infertility: A controlled comparison with tubal infertility and use of donor spermatozoa. Hum Reprod 1998;13:1825-1830
24. MacDougall ML, Tan SL, Balen A, Jacbs S: A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. Hum Reprod 1993;8:233-237
25. Itskovitz-Eldor J, Kol S, Mannaerts B: Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: Preliminary report. Hum Reprod 2000;15:1965-1968